Anthracycline-induced Cardiotoxicity
📧 Sign up to get email alerts when something new happens for Anthracycline-induced Cardiotoxicity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy [NA]
This clinical trial update reports ongoing recruitment for a study using serial cardiac MRI with contrast agents and biomarker analysis to d…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial [NA]
This clinical trial assesses how different exercise intensities affect cardiac health in young adult survivors of childhood cancer, with no …
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients [Phase 4]
A Phase 4 clinical trial evaluating rosuvastatin to prevent anthracycline-induced cardiotoxicity in breast cancer patients; the study is not…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is assessing whether the nutritional supplement sulforaphane can protect against doxorubicin-related cardio…
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity [NA]
A clinical trial evaluating myocardial fibrosis identification in patients with anthracycline-induced cardiotoxicity; current status is unkn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Ivabradine to Prevent Anthracycline-induced Cardiotoxicity [Phase 3]
A Phase 3 clinical trial evaluating ivabradine to prevent cardiotoxicity from anthracycline chemotherapy in patients with cancer.